3:05 – 5:05 p.m., S.J. Quinney College of Law, Room 4609
The Law and Biomedicine Colloquium brings together scholars, practitioners in our community, law students, and law faculty for seminar-style discussion of complex and controversial topics in the field. We are excited to be welcoming four distinguished scholars from other law schools in the region, as well as leaders in legal practice in law and the biosciences. Registered students at the College of Law will receive one hour of credit for participating in the colloquium; other interested participants are welcome to join us. Visit the Center web page to learn more about the Center for Law and Biomedical Sciences.
Speaker Sessions open to the whole University community (other sessions are held exclusively for students).
*Visitors will need to check in at the information desk on level 1 or level 2 to receive access to level 4.
Since the decision of the United States Supreme Court in Alice Corp. v. CLS Bank, lower courts have struggled to apply the Alice holding to distinguish patentable subject matter. This has been a particular challenge in biotechnology, where the distinction between products of nature and human invention remains indeterminate. In this presentation, Professor Burk will discuss the patent eligibility of clones, stem cells, diagnostic techniques, and other biotechnology inventions, and the implications current doctrines for future innovation in biomedical technologies.
Dan L. Burk is Chancellor’s Professor of Law at the University of California, Irvine, where he is a founding member of the law faculty. An internationally prominent authority on issues related to high technology, he lectures, teaches, and writes in the areas of patent, copyright, electronic commerce, and biotechnology law. He is the author of numerous papers on the legal and societal impact of new technologies, including articles on Internet regulation, on the structure of the patent system, and on the economic analysis of intellectual property law.
Professor Burk holds a B.S. in Microbiology (1985) from Brigham Young University, an M.S. in Molecular Biology and Biochemistry (1987) from Northwestern University, a J.D. (1990) from Arizona State University, and a J.S.M. (1994) from Stanford University. Prior to joining the faculty at UC Irvine, he taught at the University of Minnesota. He has served as a legal advisor to a variety of private, governmental, and intergovernmental organizations, including the American Civil Liberties Union Committee on Patent Policy and the OECD Committee on Consumer Protection.
January 11, 2017 – Stephanie Bair, Associate Professor, Brigham Young University
January 18, 2017 – Dave Gessel, Executive Vice President, Utah Hospital Association
January 25, 2017 – Suzette Goucher, JD, RN, Director Risk Management, University of Utah Hospital & Clinics
February 1, 2017 – Dan Burk, Professor, University of California, Irvine
February 8, 2017 – L. Rex Sears, Maschoff Brennan
February 15, 2017 – Teneille Brown, Professor of Law and Adjunct Professor of Internal Medicine, University of Utah
February 22, 2017 – Katherine L. Watson, Associate Professor of Medical Education and Obstetrics and Gynecology, Northwestern University
March 1, 2017 – Liza Vertinsky, Assistant Professor, Emory University